Per Larsson

2.1k total citations
43 papers, 1.4k citations indexed

About

Per Larsson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Ecology. According to data from OpenAlex, Per Larsson has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 4 papers in Ecology. Recurrent topics in Per Larsson's work include Inhalation and Respiratory Drug Delivery (24 papers), Asthma and respiratory diseases (14 papers) and Neonatal Respiratory Health Research (9 papers). Per Larsson is often cited by papers focused on Inhalation and Respiratory Drug Delivery (24 papers), Asthma and respiratory diseases (14 papers) and Neonatal Respiratory Health Research (9 papers). Per Larsson collaborates with scholars based in Sweden, United Kingdom and United States. Per Larsson's co-authors include Björn Bake, Anna‐Carin Olin, Evert Ljungström, Ann‐Charlotte Almstrand, Ekaterina Mirgorodskaya, Anna Bredberg, Umesh Lalloo, Tito Atienza, Pál Magyar and Klaus F. Rabe and has published in prestigious journals such as The Lancet, Gastroenterology and PLoS ONE.

In The Last Decade

Per Larsson

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Larsson Sweden 20 957 555 182 142 126 43 1.4k
Susanne J. H. Vijverberg Netherlands 27 652 0.7× 1.1k 2.0× 130 0.7× 73 0.5× 247 2.0× 97 1.9k
Jakob Usemann Switzerland 18 539 0.6× 302 0.5× 139 0.8× 72 0.5× 144 1.1× 72 1.0k
M.H. Becquemin France 18 685 0.7× 284 0.5× 91 0.5× 244 1.7× 104 0.8× 51 1.4k
Hyouk‐Soo Kwon South Korea 27 613 0.6× 690 1.2× 37 0.2× 132 0.9× 323 2.6× 98 2.2k
Richard C. Ahrens United States 25 2.4k 2.6× 1.1k 2.0× 87 0.5× 164 1.2× 40 0.3× 60 2.8k
Michael Schivo United States 20 466 0.5× 354 0.6× 367 2.0× 94 0.7× 59 0.5× 54 1.1k
Antonio Molino Italy 23 629 0.7× 603 1.1× 56 0.3× 110 0.8× 396 3.1× 84 1.8k
Anna Agnese Stanziola Italy 20 626 0.7× 481 0.9× 39 0.2× 68 0.5× 159 1.3× 67 1.3k
Haim Bibi Israel 24 589 0.6× 390 0.7× 27 0.1× 173 1.2× 179 1.4× 79 1.5k
G. Scheuch Germany 29 2.5k 2.7× 753 1.4× 240 1.3× 158 1.1× 566 4.5× 116 3.3k

Countries citing papers authored by Per Larsson

Since Specialization
Citations

This map shows the geographic impact of Per Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Larsson more than expected).

Fields of papers citing papers by Per Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Larsson. The network helps show where Per Larsson may publish in the future.

Co-authorship network of co-authors of Per Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Per Larsson. A scholar is included among the top collaborators of Per Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Larsson. Per Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larsson, Per, et al.. (2025). Changes in the pulmonary surfactant in patients with mild to moderate COVID-19. PLoS ONE. 20(8). e0325153–e0325153.
2.
García-Velasco, Juan A., Manuel Fernández Sánchez, Per Larsson, & Bernadette Mannaerts. (2025). A single dose of corifollitropin alfa is equipotent to a daily dose of 300 IU recombinant FSH regardless of ovarian reserve. Reproductive BioMedicine Online. 51(3). 104987–104987.
3.
Larsson, Per, Olaf Holz, Grielof Koster, et al.. (2023). Exhaled breath particles as a novel tool to study lipid composition of epithelial lining fluid from the distal lung. BMC Pulmonary Medicine. 23(1). 423–423. 5 indexed citations
4.
Larsson, Per, Rickard Nordén, Maria Andersson, et al.. (2022). Severe acute respiratory syndrome coronavirus 2 can be detected in exhaled aerosol sampled during a few minutes of breathing or coughing. Influenza and Other Respiratory Viruses. 16(3). 402–410. 15 indexed citations
5.
6.
Bake, Björn, et al.. (2019). Exhaled particles and small airways. Respiratory Research. 20(1). 8–8. 144 indexed citations
7.
Larsson, Per, Björn Bake, Anita Wallin, et al.. (2017). The effect of exhalation flow on endogenous particle emission and phospholipid composition. Respiratory Physiology & Neurobiology. 243. 39–46. 31 indexed citations
8.
Lärstad, Mona, Ann‐Charlotte Almstrand, Per Larsson, et al.. (2015). Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study. PLoS ONE. 10(12). e0144463–e0144463. 32 indexed citations
9.
Heldal, Kari Kulvik, Lars Barregård, Per Larsson, & Dag G. Ellingsen. (2012). Pneumoproteins in sewage workers exposed to sewage dust. International Archives of Occupational and Environmental Health. 86(1). 65–70. 22 indexed citations
10.
Ljungström, Evert, et al.. (2012). Effects of breath holding at low and high lung volumes on amount of exhaled particles. Respiratory Physiology & Neurobiology. 185(2). 228–234. 35 indexed citations
11.
Larsson, Per, Ekaterina Mirgorodskaya, Lena Samuelsson, et al.. (2011). Surfactant protein A and albumin in particles in exhaled air. Respiratory Medicine. 106(2). 197–204. 40 indexed citations
12.
Olsén, Lena, Carina Ingvast-Larsson, Hans Broström, Per Larsson, & Hans Tjälve. (2007). Clinical signs and etiology of adverse reactions to procaine benzylpenicillin and sodium/potassium benzylpenicillin in horses. Journal of Veterinary Pharmacology and Therapeutics. 30(3). 201–207. 19 indexed citations
13.
Rabe, Klaus F., Tito Atienza, Pál Magyar, et al.. (2006). Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. The Lancet. 368(9537). 744–753. 293 indexed citations
14.
Thorsson, Lars, et al.. (2003). Systemic availability and lung deposition of budesonide via three different nebulizers in adults. Annals of Allergy Asthma & Immunology. 90(2). 226–232. 27 indexed citations
15.
Edsbäcker, Staffan, Per Larsson, & Per Wollmer. (2002). Gut delivery of budesonide, a locally active corticosteroid, from plain and controlled-release capsules. European Journal of Gastroenterology & Hepatology. 14(12). 1357–1362. 31 indexed citations
16.
Jensen, K. Thomas & Per Larsson. (2002). Predator evasion in Daphnia: the adaptive value of aggregation associated with attack abatement. Oecologia. 132(3). 461–467. 14 indexed citations
17.
Rosenborg, Johan, Thomas Bengtsson, Per Larsson, et al.. (2000). Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics. European Journal of Clinical Pharmacology. 56(5). 363–370. 48 indexed citations
18.
Larsson, Per, et al.. (1999). Dose response studies: how do we make them conclusive?. Statistics in Medicine. 18(6). 629–641. 17 indexed citations
19.
Boorsma, Martin, et al.. (1996). Assessment of the relative systemic potency of inhaled fluticasone and budesonide. European Respiratory Journal. 9(7). 1427–1432. 80 indexed citations
20.
Edsbäcker, Staffan, et al.. (1995). Budesonide controlled ileal release (CIR) capsules affect plasma cortisol less than prednisolone. Gastroenterology. 108(4). A814–A814. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne J. H. Vijverberg Breakdown of academic impact, for papers by Jakob Usemann Breakdown of academic impact, for papers by M.H. Becquemin Breakdown of academic impact, for papers by Hyouk‐Soo Kwon Breakdown of academic impact, for papers by Richard C. Ahrens Breakdown of academic impact, for papers by Michael Schivo Breakdown of academic impact, for papers by Antonio Molino Breakdown of academic impact, for papers by Anna Agnese Stanziola Breakdown of academic impact, for papers by Haim Bibi Breakdown of academic impact, for papers by G. Scheuch
Rankless by CCL
2026